Pfizer 3-dose COVID-19 vaccine 80 per cent effective in kids aged under five
Story highlights
The company said in its statement that the vaccine has produced extremely positive results in the tests till now and if authorised, the vaccine will comprise of three shots of three micrograms each.
Pfizer has said that the three-dose vaccine created by them has shown 80 per cent effectiveness against the Omicron COVID-19 infection among children aged between six months and five years.
This is good news for parents as cases continue to rise once again around the world and according to the timeline presented by Pfizer, the vaccine is expected to be authorised by July this year. The company said in its statement that the vaccine has produced extremely positive results in the tests till now and if authorised, the vaccine will comprise of three shots of three micrograms each.
“We are pleased that our formulation for the youngest children, which we carefully selected to be one-tenth of the dose strength for adults, was well tolerated and produced a strong immune response,” said Albert Bourla, Pfizer's chairman and chief executive officer in the statement.
trending now
)
Pakistan's stock rally ignited by foreign investors hits four-year high
)
'Go f**k yourself': Elon Musk's profanity-laden answer to advertisers suspending ads on X - WATCH
)
Navigating the Net-Zero Frontier: Insights from the world economic forum's industry tracker 2023
)
Piggybacking on USA's allegations, Trudeau urges India to take Canada's claims seriously
)
Big Bang Theory star condemns global silence on 'rape and torture' of Israeli women by Hamas
)
'My answer is...': Israeli PM Netanyahu reveals what will happen after truce deal expires
)
IND vs AUS 4th T20 live streaming: How to watch India vs Australia 4th T20 match live on mobile app, TV
)
Google forced to cough $74 million annually after reaching deal with Canada to keep news in search results
)
Disney CEO Bob Iger vows Marvel quality revival after box office setbacks
)
Eight-year-old boy, teenager shot dead in West Bank, says Palestinian health ministry
)
COP28 summit Dubai LIVE: Spotlight on global leaders for urgent action over climate crisis
)
Wilders' PM hopes fading? Key party walks out of proposed coalition
)
Telangana elections: Polling underway for 119 assembly seats; PM Modi urges voters to vote in ‘record numbers’
)
Not a meteorite, but India's Deccan Traps led to extinction of dinosaurs from Earth: study
)
Pat Cummins, Mitchell Starc headline IPL auctions ahead of registration deadline day
The development meant that Pfizer are closer to getting an emergency use authorisation for the vaccine and according to ABC News, the FDA will be reviewing their application on June 21 and 22.
If authorised, the company will be able to release the vaccine in the market by July and according to experts, the high efficacy against symptomatic COVID-19 infection can be great news for patients.
However, Pfizer has made it clear that the results are preliminary and they will be conducting more tests in the future. They also warned that there can be some side effects from the vaccines in all age groups and they are looking to test it on a larger sample to verify all of their results.
)
